The Anglonordic Life Science Conference XIV is now entering its fourteenth year and is by-invitation-only. The select audience is restricted to decision makers representing drug discovery and technology companies from the UK and Nordic regions along with international pharmaceutical and investment firms. Service suppliers can only attend as sponsors or exhibitors. At the 2016 event, 70 investment firms attended.

Discounts available for MediWales members.

For more information click here.